Y-mAbs Therapeutics Inc (NASDAQ:YMAB)

14.50
Delayed Data
As of 3:59pm ET
 +0.54 / +3.87%
Today’s Change
6.50
Today|||52-Week Range
30.16
-10.55%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$610.3M

Company Description

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.

Contact Information

Y-mAbs Therapeutics, Inc.
230 Park Avenue
New York New York 10169-0005
P:(646) 885-8505
Investor Relations:

Employees

Shareholders

Mutual fund holders46.54%
Individual stakeholders21.76%
Other institutional13.36%

Top Executives

Thomas GadPresident, Chief Executive Officer & Director
Joris Wiel Jan WilmsChief Operating Officer & Senior Vice President
Bo KruseCFO, Secretary. Treasurer & Executive VP
Torben Lund-HansenChief Technology Officer & Senior Vice President
Steen LisbyChief Scientific Officer & Senior Vice President